基于母体特征、孕11-13周血清妊娠相关血浆蛋白-A和胎盘生长因子的竞争风险模型预测小于胎龄儿
该前瞻性观察研究纳入60 875例单胎妊娠孕妇,在孕11+0至13+6周行常规超声检查时检测PAPP-A和PlGF,构建竞争风险模型预测小于胎龄儿。模型在固定10%假阳性率下,对出生体重<第10百分位且分娩≥37周、<37周和<32周的SGA检出率分别为33.8%、43.8%和48.4%。PlGF预测SGA优于PAPP-A,尤其在合并子痫前期时。
要点
- 孕11-13周联合母体特征、PAPP-A和PlGF可个体化预测SGA风险。
- 固定10%假阳性率下,模型对<37周分娩的SGA检出率为43.8%。
- PlGF预测早产SGA优于PAPP-A,合并子痫前期时差异更明显。
核心结论
- 联合PAPP-A、PlGF与母体特征按贝叶斯定理可改善SGA预测,PlGF预测SGA优于PAPP-A,尤其合并子痫前期时。
研究设计与样本
- 前瞻性观察研究,纳入60 875例单胎妊娠孕妇,于孕11+0至13+6周行常规超声检查并检测PAPP-A和PlGF,采用折叠平面回归模型构建似然函数,结合母体历史模型按贝叶斯定理计算个体化分娩孕周和出生体重Z-score分布。
诊断标准与关键数值
- 固定假阳性率10%时,联合母体特征、PlGF和PAPP-A对出生体重<第10百分位且分娩≥37周、<37周和<32周的SGA检出率分别为33.8%、43.8%和48.4%;对出生体重<第3百分位者分别为38.6%、48.7%和51.0%。
临床应用与阅片要点
- 该模型可针对任意期望的出生体重Z-score和分娩孕周切点计算风险,并可根据每个孕妇和临床需求个体化调整。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To expand a new competing-risks model for prediction of a small-for-gestational-age (SGA) neonate, by the addition of pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF), and to evaluate and compare PAPP-A and PlGF in predicting SGA.
METHODS: This was a prospective observational study of 60 875 women with singleton pregnancy undergoing routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation. We fitted a folded-plane regression model for the PAPP-A and PlGF likelihoods. A previously developed maternal history model and the likelihood models were combined, according to Bayes' theorem, to obtain individualized distributions for gestational age (GA) at delivery and birth-weight Z-score. We assessed the discrimination and calibration of the model. McNemar's test was used to compare the detection rates for SGA with, without or independently of pre-eclampsia (PE) occurrence, of different combinations of maternal history, PAPP-A and PlGF, for a fixed false-positive rate.
RESULTS: The distributions of PAPP-A and PlGF depend on both GA at delivery and birth-weight Z-score, in the same continuous likelihood, according to a folded-plane regression model. The new approach offers the capability for risk computation for any desired birth-weight Z-score and GA at delivery cut-off. PlGF was consistently and significantly better than PAPP-A in predicting SGA delivered before 37 weeks, especially in cases with co-existence of PE. PAPP-A had similar performance to PlGF for the prediction of SGA without PE. At a fixed false-positive rate of 10%, the combination of maternal history, PlGF and PAPP-A predicted 33.8%, 43.8% and 48.4% of all cases of a SGA neonate with birth weight < 10th percentile delivered at ≥ 37, < 37 and < 32 weeks' gestation, respectively. The respective values for birth weight < 3rd percentile were 38.6%, 48.7% and 51.0%. The new model performed well in terms of risk calibration.
CONCLUSIONS: The combination of PAPP-A and PlGF values with maternal characteristics, according to Bayes' theorem, improves prediction of SGA. PlGF is a better predictor of SGA than PAPP-A, especially when PE is present. The new competing-risks model for SGA can be tailored to each pregnancy and to the relevant clinical requirements. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Papastefanou I, Wright D, Lolos M, et al. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2021. PMID: 32936500. doi:10.1002/uog.23118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。